Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement...

Por Durán-Barragán, S., McGwin, G., Vilá, L. M., Reveille, J. D., Alarcón, G. S.
Publicado em 2008

A phase I study of cabozantinib (XL184) in patients with renal cell cancer

Por Choueiri, T. K., Pal, S. K., McDermott, D. F., Morrissey, S., Ferguson, K. C., Holland, J., Kaelin, W. G., Dutcher, J. P.
Publicado no Ann Oncol (2014)

C-C Motif Chemokine 5 Attenuates Angiotensin II–Dependent Kidney Injury by Limiting Renal Macrophage Infiltration

Por Rudemiller, Nathan P., Patel, Mehul B., Zhang, Jian-dong, Jeffs, Alexander D., Karlovich, Norah S., Griffiths, Robert, Kan, Matthew J., Buckley, Anne F., Gunn, Michael D., Crowley, Steven D.
Publicado no Am J Pathol (2016)

Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma

Por Carlo, M.I., Manley, B., Patil, S., Woo, K.M., Coskey, D.T., Redzematovic, A., Arcila, M., Ladanyi, M., Lee, W., Chen, Y.B., Lee, C.H., Feldman, D.R., Hakimi, A.A., Motzer, R.J., Hsieh, J.J., Voss, M.H.
Publicado no Kidney Cancer (2017)

Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-α as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population

Por Castellano, D., del Muro, X. Garcia, Pérez-Gracia, J. L., González-Larriba, J. L., Abrio, M. V., Ruiz, M. A., Pardo, A., Guzmán, C., Cerezo, S. Díaz, Grande, E.
Publicado em 2009

Adherence and renal biopsy feasibility in the Renin Angiotensin-System Study (RASS) primary prevention diabetes trial(,)

Por Robiner, William N., Strand, Trudy D., Mauer, Michael
Publicado no Diabetes Res Clin Pract (2013)

Amyloidogenicity and Clinical Phenotype Associated with Five Novel Mutations in Apolipoprotein A-I

Por Rowczenio, Dorota, Dogan, Ahmet, Theis, Jason D., Vrana, Julie A., Lachmann, Helen J., Wechalekar, Ashutosh D., Gilbertson, Janet A., Hunt, Toby, Gibbs, Simon D.J., Sattianayagam, Prayman T., Pinney, Jenny H., Hawkins, Philip N., Gillmore, Julian D.
Publicado em 2011

Renal Nitric Oxide Synthase and Antioxidant Preservation in Cyp1a1-Ren-2 Transgenic Rats With Inducible Malignant Hypertension

Por Cunningham, Mark W., Sasser, Jennifer M., West, Crystal A., Milani, Carlo J., Baylis, Chris, Mitchell, Kenneth D.
Publicado em 2013

Women, renal disease and pregnancy

Por Smyth, Andrew, Radovic, Milan, Garovic, Vesna D.
Publicado em 2013

The Toll Interleukin-1 Receptor (IL-1R) 8/Single Ig Domain IL-1R-Related Molecule Modulates the Renal Response to Bacterial Infection

Por Leemans, Jaklien C., Butter, Loes M., Teske, Gwendoline J. D., Stroo, Ingrid, Pulskens, Wilco P., Florquin, Sandrine
Publicado em 2012

Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma...

Por Heng, D. Y., MacKenzie, M. J., Vaishampayan, U. N., Bjarnason, G. A., Knox, J. J., Tan, M. H., Wood, L., Wang, Y., Kollmannsberger, C., North, S., Donskov, F., Rini, B. I., Choueiri, T. K.
Publicado em 2012

Antinuclear Antibody Negative Systemic Sclerosis

Por Salazar, GA, Assassi, S, Wigley, F, Hummers, L, Varga, J, Hinchcliff, M, Khanna, D, Schiopu, E, Phillips, K, Furst, DE, Steen, V, Baron, M, Hudson, M, Taillefer, SS, Pope, J, Jones, N, Docherty, P, Khalidi, NA, Robinson, D, Simms, R, Silver, R, Frech, TM, Fessler, B, Molitor, J, Fritzler, M, Segal, B, Al-Kassab, F, Perry, M, Yang, J, Zamanian, S, Reveille, JD, Arnett, FC, Pedroza, C, Mayes, MD
Publicado no Semin Arthritis Rheum (2014)

Renal Failure and Acute Myocardial Infarction: Clinical Characteristics in Advanced Chronic Kidney Disease, Dialysis, and Non-Chronic Kidney Disease Patients. A Collaborative Project of the United States Renal Data System/National Institutes of Health and the National Registry of Myocardial Infarction

Por Shroff, Gautam R., Frederick, Paul D., Herzog, Charles A.
Publicado em 2012

Nocturnal Hypertension and Attenuated Nocturnal Blood Pressure Dipping is Common in Pediatric Lupus [version 2; referees: 2 approved, 1 approved with reservations]

Por J. Fallon Campbell, Sarah J. Swartz, Scott E. Wenderfer
Publicado em 2015-11-01

Recent advances involving the renin–angiotensin system

Por Crowley, Steven D., Coffman, Thomas M.
Publicado em 2012

Prognostic Importance of Serum Alkaline Phosphatase in CKD Stages 3–4 in a Clinical Population

Por Taliercio, Jonathan J., Schold, Jesse D., Simon, James F., Arrigain, Susana, Tang, Anne, Saab, Georges, Nally, Joseph V., Navaneethan, Sankar D.
Publicado em 2013

Vitamin D analogues to target residual proteinuria: potential impact on cardiorenal outcomes

Por Humalda, Jelmer K., Goldsmith, David J. A., Thadhani, Ravi, de Borst, Martin H.
Publicado no Nephrol Dial Transplant (2015)

P14.123 Neurological complications related to checkpoints inhibitors

Por Esparragosa, I, Valenti-Azcarate, R, Moreno-Ajona, D, Gallego Perez de Larraya, J
Publicado no Neuro Oncol (2019)

Biodistribution and Renal Clearance of Biocompatible Lung Targeted Poly(ethylene glycol) (PEG) Nanogel Aggregates

Por Deshmukh, Manjeet, Kutscher, Hilliard L., Gao, Dayuan, Sunil, Vasanthi R., Malaviya, Rama, Vayas, Kinal, Stein, Stanley, Laskin, Jeffrey D., Laskin, Debra L., Sinko, Patrick J.
Publicado em 2012

Aberrations in the epidermal growth factor receptor gene in 958 patients with diverse advanced tumors: implications for therapy

Por Wheler, J. J., Falchook, G. S., Tsimberidou, A. M., Hong, D. S., Naing, A., Piha-Paul, S. A., Chen, S. S., Fu, S., Stephen, B., Fok, J. Y., Janku, F., Kurzrock, R.
Publicado em 2013